Measurement error and variant-calling in deep Illumina sequencing of HIV
暂无分享,去创建一个
[1] P. Mieczkowski,et al. Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations , 2015, Journal of Virology.
[2] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[3] M. Busch,et al. Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil , 2014, PloS one.
[4] C. Brumme. HIV Drug Resistance Testing by High-Multiplex "Wide" , 2015 .
[5] Jeffrey N. Martin,et al. HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument , 2015, Antimicrobial Agents and Chemotherapy.
[6] A. Sönnerborg,et al. Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries. , 2014, The Journal of antimicrobial chemotherapy.
[7] Lior Pachter,et al. RESEARCH ARTICLE Open Access Identification and correction of systematic error in high-throughput sequence data , 2022 .
[8] M. Busch,et al. Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors , 2016, PloS one.
[9] Jonathan E. Allen,et al. Ultra-deep mutant spectrum profiling: improving sequencing accuracy using overlapping read pairs , 2013, BMC Genomics.
[10] K. Metzner,et al. A Comprehensive Analysis of Primer IDs to Study Heterogeneous HIV-1 Populations. , 2016, Journal of molecular biology.
[11] G. Reyes-Terán,et al. Deep sequencing: becoming a critical tool in clinical virology. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[12] Sean R. Eddy,et al. Accelerated Profile HMM Searches , 2011, PLoS Comput. Biol..
[13] Volker Roth,et al. Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations , 2014, Nucleic acids research.
[14] R. Paredes,et al. Deep sequencing for HIV-1 clinical management. , 2017, Virus research.
[15] Paul Sandstrom,et al. Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance. , 2017, The Journal of infectious diseases.
[16] J. Fellay,et al. Easy and Accurate Reconstruction of Whole HIV Genomes from Short-Read Sequence Data , 2016, bioRxiv.
[17] Sergei L. Kosakovsky Pond,et al. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] J. Franklin,et al. The elements of statistical learning: data mining, inference and prediction , 2005 .
[19] D. Katzenstein,et al. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. , 1998, The Journal of clinical investigation.
[20] Richard J Orton,et al. Distinguishing low frequency mutations from RT-PCR and sequence errors in viral deep sequencing data , 2015, BMC Genomics.
[21] C. Magis-Rodríguez,et al. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey. , 2016, The lancet. HIV.
[22] J. Mellors,et al. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA , 2016, Retrovirology.
[23] F. Zanini,et al. Error rates, PCR recombination, and sampling depth in HIV-1 whole genome deep sequencing. , 2017, Virus research.
[24] J. McPherson,et al. Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.
[25] A. Hughes,et al. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq , 2014, Retrovirology.
[26] Chris Mungall,et al. BioMake: a GNU make‐compatible utility for declarative workflow management , 2017, Bioinform..
[27] Alyssa J. Porter,et al. Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy , 2014, PloS one.
[28] K. Metzner,et al. Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data , 2012, Front. Microbio..
[29] M. Kozal,et al. Deep sequencing of HIV: clinical and research applications. , 2014, Annual review of genomics and human genetics.
[30] A. Poon,et al. Promises and pitfalls of Illumina sequencing for HIV resistance genotyping. , 2017, Virus research.
[31] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[32] Hirotaka Ode,et al. Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq , 2015, Front. Microbiol..
[33] Cassandra B. Jabara,et al. Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain. , 2015, AIDS research and human retroviruses.
[34] High-specificity detection of rare alleles with Paired-End Low Error Sequencing (PELE-Seq) , 2016, BMC Genomics.
[35] R. Neher,et al. Challenges with Using Primer IDs to Improve Accuracy of Next Generation Sequencing , 2015, PloS one.
[36] Cassandra B. Jabara,et al. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID , 2011, Proceedings of the National Academy of Sciences.
[37] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.